Drug intelligence / Profile preview

eprosartan

Development stage
Phase 4
Lead developer
Abbott
Modality
Small Molecules
Administration
Oral
01

Overview

Eprosartan is an angiotensin II receptor blocker (ARB) used primarily to treat high blood pressure (hypertension). It works by selectively blocking the binding of angiotensin II to the AT1 receptor in various tissues, including vascular smooth muscle and the adrenal gland. This blockade leads to vasodilation, reduced secretion of vasopressin and aldosterone, and ultimately a decrease in blood pressure. Eprosartan does not exhibit partial agonist activity at the AT1 receptor and has a much higher affinity for this receptor compared to AT2 receptors. It is available as an oral tablet and may be used alone or with other antihypertensive agents such as diuretics or calcium channel blockers. In addition to hypertension, it is sometimes used off-label for heart failure and diabetic nephropathy[1][2][3][4][5].

Brand names
Teveten
Other names
eprosartan mesylate
02

Targets

AGTR1 (Angiotensin II Type-1 receptor)

Beyond the preview

Go deeper on eprosartan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on eprosartan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call